CME/CE
Your professional development is critical to the care of your patients. Stay on top of the latest treatments and information with ReachMD's CME activities. Our topics span cardiology, diabetes, oncology, women's health and more. And our CME library is continuously growing, every quarter.
151-165 of 959
Treatment of Hepatic Encephalopathy: When, What, How, and Why?
MinuteCE®Treatment of Hepatic Encephalopathy: When, What, How, and Why?
Treatment of Hepatic Encephalopathy: Primary vs Secondary Prophylaxis
MinuteCE®Treatment of Hepatic Encephalopathy: Primary vs Secondary Prophylaxis
Optimizing Care of the Hospitalized Patient With Overt Hepatic Encephalopathy
MinuteCE®Optimizing Care of the Hospitalized Patient With Overt Hepatic Encephalopathy
Current Treatment of Hepatic Encephalopathy: Is It Meeting Our Patients' Needs?
MinuteCE®Current Treatment of Hepatic Encephalopathy: Is It Meeting Our Patients' Needs?
Advances in the Treatment of Overt Hepatic Encephalopathy: What's in the Pipeline?
MinuteCE®Advances in the Treatment of Overt Hepatic Encephalopathy: What's in the Pipeline?
Advances in Treatment of Hypoparathyroidism: Importance of Genetic Testing for Autosomal Dominant Hypocalcemia Type 1
CME/CE Broadcast ReplayAdvances in Treatment of Hypoparathyroidism: Importance of Genetic Testing for Autosomal Dominant Hypocalcemia Type 1
- advertisement
Inside the Cataracts Studio: Advanced Fluidics, Ergonomics, and Techniques for Complex Cases - Introducing Robotic SLACS
CME/CEInside the Cataracts Studio: Advanced Fluidics, Ergonomics, and Techniques for Complex Cases - Introducing Robotic SLACS
Taking Action Against RSV: No Child Unprotected
CME/CETaking Action Against RSV: No Child Unprotected
Rethinking Schizophrenia Treatment Through Muscarinic Modulation
CME/CERethinking Schizophrenia Treatment Through Muscarinic Modulation
Unmet Needs in Endocrine Therapy: Rethinking the HR+/HER2- mBC Treatment Roadmap
MinuteCE®Unmet Needs in Endocrine Therapy: Rethinking the HR+/HER2- mBC Treatment Roadmap
Breaking Down the Benchmarks: Pivotal Data on First-Line CDK4/6 Inhibitors
MinuteCE®Breaking Down the Benchmarks: Pivotal Data on First-Line CDK4/6 Inhibitors
- advertisement
Safety of CDK4/6 Inhibitors: Anticipation, Prevention, and Management of Adverse Events
MinuteCE®Safety of CDK4/6 Inhibitors: Anticipation, Prevention, and Management of Adverse Events
Beyond Fulvestrant: Oral SERDs Redefining ER Targeting
MinuteCE®Beyond Fulvestrant: Oral SERDs Redefining ER Targeting
The Future of Oral SERDs: Combination Strategies
MinuteCE®The Future of Oral SERDs: Combination Strategies





















































